Impact of the Oral Microbiota on Relapse in HNSCC Patients

to characterise the impact of microbiota in radiotherapy efficacy

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Head and Neck Cancer Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

ICAP

Avignon, 84918, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

head and neck cancer

Exclusion criteria

Treatment and study plan

buccal swabs

Other

buccal swabs for microbiota analysis before and after radiotherapy

Primary outcomes

Microbiota

Time frame: 2 years

Analysis of buccal microbiota by 16SrRNA gene sequencing

Sponsors and collaborators

Lead sponsor

Institut Sainte Catherine

Other

Registry information

Acronym: MICR-ORL

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2027
First posted: Feb 4, 2025
Registry last updated: Feb 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting